ExonHit is a fast emerging healthcare player active in both therapeutics and diagnostics. ExonHit is based in Paris, France, and has US offices in Gaithersburg, Maryland. The Company employs 65 associates.
Dr. Stehelin is the director of the CHRS unit for the Development and Mechanisms of Cancer at the Pasteur Institute in Lille, France. He is renowned for his work on the molecular basis of cancer and is a member of the Institut de France’s Sciences Academy.
Dr Stehelin has an M.D. and Ph.D. in Medicine and a Ph.D. in Sciences